A recent study reported that transgenic expression of LMO1 alone failed to induce tumorigenesis in a zebra fish model, but acted as a synergist of MYCN, an oncogene amplified in ~20% of neuroblastoma (32). The gene discussed is MYCN; the disease is neuroblastoma.